Abiomed Inc $24.92

down -0.05


11/7/2014 04:24 PM  |  NASDAQ : ABMD  
Industries : Health Services / Medical Appliances & Equipment
Get Trend Analysis Icon Get ABMD Trend Analysis - it has underperformed the S&P 500 by 9%

Partner Headlines

  1. Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

    Benzinga
  2. Abiomed Acquires Exclusive License for Opsens' Optical Sensor Technology

    Benzinga
  3. UPDATE: Benchmark Initiates Coverage on Abiomed on Potential of Impella ...

    Benzinga
  4. Abiomed Wins Federal Contract to Provide Impalla Platform to Vets

    Benzinga
  5. Abiomed profit dips on costs

    IBD
  6. Mid-Day Market Update: Markets Largely Flat, Groupon Boosts

    Benzinga
  7. Abiomed Shares Lower as FDA Panel Votes to Retain Class III Status for ...

    Benzinga
  8. Medical Device Makers: Repeal the New Tax!

    FoxBusiness
  9. Abiomed Says Class Action Lawsuit Without Merit; Intends to Defend Vigorously

    Benzinga
  10. Benzinga's Top Initiations

    Benzinga
  11. ABIOMED Plunges After Revealing Government Investigation; Stock Loses 33%

    Benzinga
  12. Benzinga Mid-Day Market Update

    Benzinga
  13. Lennar, Other Homebuilders Crush Profit Estimates

    IBD
  14. Health Care Sector Wrap

    FoxBusiness
  15. Health Care Sector Wrap

    FoxBusiness
  16. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 15,000 Shares

    GuruFocus
  17. Abiomed heart pump sales pop

    IBD
  18. Abiomed's Heart Pumps Pound Q1 Expectations

    IBD
  19. Abiomed Earnings Beat Estimates, But Shares Fall

    IBD
  20. Abiomed Earnings Beat Estimates, But Shares Fall

    IBD
  21. Thoratec Reports Mixed Q2; Abiomed Waits In Wings

    IBD
  22. Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX

    GuruFocus
  23. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 16,715 Shares

    GuruFocus
  24. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 8,556 Shares

    GuruFocus
  25. ABIOMED Inc. (ABMD) CFO Robert Bowen sells 7,316 Shares

    GuruFocus
  26. UPDATE: Piper Jaffray Raises Price Target on Abiomed to $27

    Benzinga
  27. UPDATE: Wunderlich Securities Raises PT to $29 on Abiomed; Impella Exceeds ...

    Benzinga
  28. Abiomed expects strong sales

    IBD
  29. Abiomed Stock Reverses From High Despite Strong Sales

    IBD
  30. Abiomed Stock Hits High After Q4 Sales Top Estimates

    IBD
  31. Earnings Scheduled For May 16

    Benzinga
  32. Notable Call Options Activity in Abiomed

    Benzinga
  33. UPDATE: Piper Jaffray Raises PT to $25 on ABIOMED

    Benzinga
  34. UPDATE: Wunderlich Securities Raises PT on Abiomed to $27

    Benzinga
  35. Wunderlich Raises PT on Abiomed to $27

    Benzinga
  36. Wunderlich Securities Maintains Buy Rating on Abiomed

    Benzinga
  37. Rodman & Renshaw Downgrades Abiomed to Market Underperform

    Benzinga
  38. Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth ...

    Benzinga
Trading Center